KYF has officially become the company’s controlling shareholder, and Mr. Liu Xirong is the company’s actual controller.
Company Profile
The company is listed on the Shanghai Stock Exchange.
Total land area of the company
The company currently has more than 500 employees.
Holds various domestic and international patents.
Ningxia Zhongke Biotechnology Co., Ltd.
Hereinafter referred to as the "Company" or "NINGKE".
Stock code:
600165
The company’s predecessor was Ningxia Hengli Steel Wire Rope Co., Ltd.Listed on the Shanghai Stock Exchange on May 29, 1998, marking the start of its journey toward capitalization and development.In 2017, the company’s strategic transformation focused on the field of biomanufacturing. We successfully introduced third-generation lauric acid production technology—developed by the Institute of Microbiology, Chinese Academy of Sciences, and possessing independent intellectual property rights—and built a 50,000-ton-per-year lauric acid production facility in the Shizuishan Economic and Technological Development Zone in Ningxia. Thanks to its technological innovation and industry-leading position, this project was successfully selected for the Chinese Academy of Sciences’ “Hongguang Special Program.”
The company is rooted in synthetic biology-based biomanufacturing and has established a diversified business portfolio as well as a well-rounded subsidiary operating system.Our business covers a range of long-chain dicarboxylic acids, bio-based food and health products, and animal feed, thus establishing a development model characterized by “core products leading and related industries collaborating.”
As a wholly-owned subsidiary of NINGKE and the core production base for long-chain dicarboxylic acids, Zhongke Xincai was established in June 2017. It covers a total area of 750 mu and currently employs over 500 people. Relying on its strong technological capabilities and standardized operational management, Zhongke Xincai has successfully been recognized as a “National High-Tech Enterprise.” Moreover, it has taken the lead in establishing two autonomous-region-level research platforms—the “Ningxia Bio-based Long-Chain New Materials Engineering Technology Research Center” and the “Ningxia Long-Chain Biomaterials Manufacturing Engineering Research Center”—thus building a comprehensive innovation system spanning from basic research and pilot-scale amplification to industrial-scale production. The company strictly adheres to quality control standards and has obtained GB/T19001-2016 quality management system certification. It currently holds nearly 20 independently owned intellectual property patents, with its core technologies ranking among the leading ones in China.
The company’s core product, long-chain dicarboxylic acid, is a green chemical new material that is strongly promoted by the Chinese government. It is produced using a biosynthetic process and, compared to conventional chemical synthesis methods, boasts significant advantages such as lower energy consumption, reduced pollution, higher product purity, and greater stability in performance. This product serves as a key raw material in the polyamide industry chain and is widely used in the production of high-end nylon, advanced fragrance intermediates, premium lubricants, highly effective rust inhibitors, environmentally friendly hot-melt adhesives, specialty synthetic fibers, and a host of other high-value-added chemical products. Its end-use applications span across multiple strategic emerging sectors, including automotive, electronics and electrical appliances, aerospace, high-end equipment, and military technology.
Relying on its core technologies and high-quality products, NINGKE has grown into a leading new materials enterprise that is being specially cultivated and supported by the Ningxia Hui Autonomous Region. It has also been included in the list of key backbone enterprises for the “9+3” specialized and characteristic industries in Shizuishan City, playing a pivotal role in regional industrial upgrading and green development. The company consistently regards long-chain dicarboxylic acid technology as its core driving force, continuously increasing R&D investment in downstream product series with high added value, and deeply cultivating the entire polyamide industry chain. It is fully committed to promoting the integrated development of the long-chain dicarboxylic acid industry system and its upstream and downstream linked industrial chains, thereby facilitating the large-scale application of bio-based long-chain polyamide materials in high-end fields and injecting new momentum into the high-quality development of the industry.
In the future, the company will firmly seize the strategic opportunities presented by the development of the synthetic biology industry during the 15th Five-Year Plan period. Upholding the corporate spirit of “self-reliance and relentless advancement, pursuing excellence,” and staying true to our original mission of “serving the country through industry and promoting green development,” we will take “improving industrial quality and fostering green development” as our guiding principle. We will simultaneously emphasize both R&D and production, as well as innovation and empowerment.The company will continue to strengthen its independent innovation capabilities in core technologies, constantly expand its upstream and downstream collaborative ecosystem, precisely align with market demands, and wholeheartedly move toward high-end, large-scale, and specialized development. We are committed to becoming a domestically leading and internationally renowned bio-manufacturing enterprise, working in synergy with partners across the industrial chain to jointly build a new paradigm of green manufacturing and high-quality development..
Development History
Corporate culture
Corporate Vision
Become a globally leading and respected value creator in the field of bio-manufacturing based on synthetic biology technologies.
Corporate Mission
Through innovative technologies and outstanding operations, we provide customers with high-quality products and services, create a platform for our employees, deliver returns to our shareholders, and make positive contributions to society.
Core Values
Customer first, integrity and responsibility, pursuit of excellence, collaborative innovation, people-oriented.
Corporate Spirit
Self-reliance and striving forward, pursuing excellence.
Business Philosophy
Green Intelligent Manufacturing—Empowering the Ecosystem; Quality as the Foundation—Trusted at Our Core; Innovation-Driven—Leading the Way to Upgrades; Value Co-creation—Achieving Win-Win Development.
Core positioning
With synthetic biology technology at its core, we focus on the core business of bio-manufacturing long-chain dicarboxylic acids. Guided by the business philosophy of "green intelligent manufacturing, quality-driven foundation, innovation-driven, and value co-creation," we are committed to becoming a globally leading supplier of green bio-based materials, empowering industrial upgrades and sustainable development.
Honors and Qualifications
Relying on its strong technological R&D capabilities and standardized operational management system, Zhongke Xincai has successfully been recognized as a “National High-Tech Enterprise” and has taken the lead in establishing several autonomous-region-level scientific research and innovation platforms—including the “Ningxia Bio-based Long-Chain New Materials Engineering Technology Research Center,” the “Ningxia Long-Chain Bio-manufacturing Materials Engineering Research Center,” the “Ningxia Bio-based Materials Engineering Manufacturing Innovation Center,” and the “Ningxia Small Highland for Talent Development in the R&D of Long-Chain Dibasic Acid Bio-new Materials.” These platforms have helped build a comprehensive innovation ecosystem spanning the entire chain—from basic R&D and pilot-scale amplification to industrial-scale production.
The company has consistently adhered to stringent quality control standards and successfully obtained GB/T19001-2016 certification for its quality management system. To date, the company has accumulated nearly 20 patents with independent intellectual property rights, and its core technical indicators have reached a domestically leading level, providing a solid foundation for the company’s high-quality development.
Has patents with independent intellectual property rights